TSXgroup

February 11, 2008

MEDX HEALTH CORP. ("MDX")
BULLETIN TYPE: New Listing- Shares
BULLETIN DATE: February 11, 2008
TSX Venture Tier 2 Company

The Company's Public Offering Prospectus dated January 10, 2008, has been filed with and accepted by TSX Venture Exchange, and filed with and receipted by the British Columbia Securities Commission, the Alberta Securities Commission, the Manitoba Securities Commission and the Ontario Securities Commission on January 10, 2008, pursuant to the provisions of the respective securities legislations.

The gross proceeds received by the Company for the Offering were $4,088,000 (5,110,000 units at $0.80 per unit). The Company is classified as a ''medical device manufacturing" company.

Commence Date: At the opening February 12, 2008, the Common shares will commence trading on TSX Venture Exchange.

Corporate Jurisdiction: Ontario

Capitalization: unlimited number of common shares with no par value of which 22,222,776 common shares are issued and outstanding.

Escrowed Shares: 7,973,415 common shares 1,440,411 common share purchase warrants 1,382,500 stock options.

Transfer Agent: Equity Transfer & Trust Company
Trading Symbol: MDX
CUSIP Number: 585090 10 3
Agent: Research Capital Corporation

Agent's Options: 511,000 non-transferable options. One option to purchase one unit at $0.80 per unit up to 24 months from the closing of the Offering. Each unit consists of one common share and one warrant, with each warrant exercisable into one common share at $0.90 per share up to 24 months from the closing of the Offering.

For further information, please refer to the Company's Prospectus dated January 10, 2008.

Company Contact: Philip Passy, President & CEO
Company Address: 3350 Ridgeway Drive, Unit 3, Mississauga, Ontario L5L 5Z9

Company Phone Number: (905) 826-0766
Company Fax Number: (905)826-0086